文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

循环中去磷酸化未羧化基质Gla蛋白水平随时间升高与更差生存相关:前瞻性马斯特里赫特重症COVID队列

Higher levels of circulating desphospho-uncarboxylated matrix Gla protein over time are associated with worse survival: the prospective Maastricht Intensive Care COVID cohort.
PubMed 文献 · J Intensive Care · 2023-12-18
一句话结论COVID-19 ICU患者插管后4周内dp-ucMGP水平较高与ICU死亡相关,独立于年龄、性别和APACHE II评分,但与肺栓塞无关。

本研究纳入112例确诊COVID-19的ICU患者,在气管插管后4周内连续测量去磷酸化未羧化基质Gla蛋白(dp-ucMGP),所有患者行CT肺动脉造影排除肺栓塞。插管时dp-ucMGP每升高100 pmol/L,ICU死亡OR为1.056(95%CI 0.977-1.141,p=0.172),6个月死亡OR为1.059(95%CI 0.976-1.059,p=0.170),均未达统计学显著。调整年龄、性别和APACHE II评分后,ICU非存活者dp-ucMGP随时间平均水平较存活者高167 pmol/L(95%CI 4-332,p=0.047);进一步调整CRP、肌酐和香豆素使用史后差异为199 pmol/L(95%CI 50-346,p=0.010);再调整冠状动脉钙化评分后差异为213 pmol/L(95%CI 3-422,p=0.051)。回归斜率(随时间变化趋势)无差异,dp-ucMGP与肺栓塞无关。

要点

  • 插管时dp-ucMGP每升高100 pmol/L,ICU死亡OR 1.056(95%CI 0.977-1.141,p=0.172),6个月死亡OR 1.059(95%CI 0.976-1.059,p=0.170),均未达统计学显著。
  • 调整年龄、性别、APACHE II后,ICU非存活者dp-ucMGP随时间平均水平较存活者高167 pmol/L(95%CI 4-332,p=0.047)。
  • 进一步调整CRP、肌酐、香豆素使用史后差异为199 pmol/L(95%CI 50-346,p=0.010);再调整CAC评分后差异为213 pmol/L(95%CI 3-422,p=0.051)。
  • dp-ucMGP随时间变化的回归斜率在ICU存活者与非存活者间无差异。
  • dp-ucMGP与肺栓塞无关联。

适用人群与场景

  • 纳入112例确诊COVID-19的ICU患者,均在气管插管后4周内连续测量dp-ucMGP。
  • 所有患者行CT肺动脉造影以排除肺栓塞。

研究设计与关键结果

  • 研究类型为前瞻性队列(马斯特里赫特重症COVID队列),纳入112例确诊COVID-19的ICU患者,插管后4周内连续测量dp-ucMGP,所有患者行CTPA排除肺栓塞,结果调整患者特征、疾病严重程度评分、炎症、肾功能、香豆素使用史和冠状动脉钙化评分。
  • 插管时dp-ucMGP每100 pmol/L,ICU死亡OR 1.056(95%CI 0.977-1.141,p=0.172),6个月死亡OR 1.059(95%CI 0.976-1.059,p=0.170),均未达统计学显著。
  • 调整年龄、性别、APACHE II评分后,ICU非存活者dp-ucMGP随时间平均水平较存活者高167 pmol/L(95%CI 4-332,p=0.047);进一步调整CRP、肌酐、香豆素使用史后差异为199 pmol/L(95%CI 50-346,p=0.010);再调整CAC评分后差异为213 pmol/L(95%CI 3-422,p=0.051)。
  • 反映随时间变化的回归斜率在ICU存活者与非存活者间无差异。
  • dp-ucMGP与肺栓塞无关联。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在COVID-19 ICU患者中,插管后4周内连续监测dp-ucMGP可能有助于识别ICU死亡风险较高的患者,但插管时单次dp-ucMGP与ICU死亡及6个月死亡的关联未达统计学显著。
  • dp-ucMGP与肺栓塞无关联,不支持将其作为排除肺栓塞的指标。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Extra-hepatic vitamin K-status, measured by dephosphorylated uncarboxylated matrix Gla protein (dp-ucMGP), maintains vascular health, with high levels reflecting poor vitamin K status. The occurrence of extra-hepatic vitamin K deficiency throughout the disease of COVID-19 and possible associations with pulmonary embolism (PE), and mortality in intensive care unit (ICU) patients has not been studied. The aim of this study was to investigated the association between dp-ucMGP, at endotracheal intubation (ETI) and both ICU and six months mortality. Furthermore, we studied the associations between serially measured dp-ucMGP and both PE and mortality.

METHODS: We included 112 ICU patients with confirmed COVID-19. Over the course of 4 weeks after ETI, dp-ucMGP was measured serially. All patients underwent computed tomography pulmonary angiography (CTPA) to rule out PE. Results were adjusted for patient characteristics, disease severity scores, inflammation, renal function, history of coumarin use, and coronary artery calcification (CAC) scores.

RESULTS: Per 100 pmol/L dp-ucMGP, at ETI, the odds ratio (OR) was 1.056 (95% CI: 0.977 to 1.141, p = 0.172) for ICU mortality and 1.059 (95% CI: 0.976 to 1.059, p = 0.170) for six months mortality. After adjustments for age, gender, and APACHE II score, the mean difference in plasma dp-ucMGP over time of ICU admission was 167 pmol/L (95% CI: 4 to 332, p = 0.047). After additional adjustments for c-reactive protein, creatinine, and history of coumarin use, the difference was 199 pmol/L (95% CI: 50 to 346, p = 0.010). After additional adjustment for CAC score the difference was 213 pmol/L (95% CI: 3 to 422, p = 0.051) higher in ICU non-survivors compared to the ICU survivors. The regression slope, indicating changes over time, did not differ. Moreover, dp-ucMGP was not associated with PE.

CONCLUSION: ICU mortality in COVID-19 patients was associated with higher dp-ucMGP levels over 4 weeks, independent of age, gender, and APACHE II score, and not explained by inflammation, renal function, history of coumarin use, and CAC score. No association with PE was observed. At ETI, higher levels of dp-ucMGP were associated with higher OR for both ICU and six month mortality in crude and adjusted modes, although not statistically significantly.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Mulder MMG, Schellens J, Sels JEM, et al. Higher levels of circulating desphospho-uncarboxylated matrix Gla protein over time are associated with worse survival: the prospective Maastricht Intensive Care COVID cohort. J Intensive Care. 2023. PMID: 38111069. doi:10.1186/s40560-023-00712-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。